Impact of intestinal ERβ on the colon transcriptome during colitis-induced tumor development
RNA-seq (gene expression) · mouse · 38 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 38 samples: 8 conditions, mostly with about 5 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Intestinal estrogen receptor beta modulates the murine colon tumor immune microenvironmentCancer letters · 2025
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE271135_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1130036 and SRA study SRP517100. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 8 samples read as cases, 10 as controls.
How we read this: 8 replicated groups read from 38 sample titles; they account for 38 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8370269 Female ERβKOVil, Vehicle, Scrape, rep 1 Female ERβKOVil, Vehicl…
- GSM8370270 Female ERβKOVil, Vehicle, Scrape, rep 2 Female ERβKOVil, Vehicl…
- GSM8370271 Female ERβKOVil, Vehicle, Scrape, rep 3 Female ERβKOVil, Vehicl…
- GSM8370272 Female ERβKOVil, Vehicle, Scrape, rep 4 Female ERβKOVil, Vehicl…
- GSM8370273 Female ERβKOVil, Vehicle, Scrape, rep 5 Female ERβKOVil, Vehicl…
- GSM8370274 Female ERβKOVil, AOM/DSS, 15 weeks, Scrape, rep 1 Female ERβKOVil, AOM/DS…
- GSM8370275 Female ERβKOVil, AOM/DSS, 15 weeks, Scrape, rep 2 Female ERβKOVil, AOM/DS…
- GSM8370276 Female ERβKOVil, AOM/DSS, 15 weeks, Scrape, rep 3 Female ERβKOVil, AOM/DS…
- GSM8370277 Female ERβKOVil, AOM/DSS, 15 weeks, Scrape, rep 4 Female ERβKOVil, AOM/DS…
- GSM8370278 Female ERβKOVil, AOM/DSS, 15 weeks, Scrape, rep 5 Female ERβKOVil, AOM/DS…
- GSM8370279 Female ERβKOVil, AOM/DSS, 15 weeks, Tumor, rep 1 Female ERβKOVil, AOM/DS…
- GSM8370280 Female ERβKOVil, AOM/DSS, 15 weeks, Tumor, rep 2 Female ERβKOVil, AOM/DS…
- GSM8370281 Female ERβKOVil, AOM/DSS, 15 weeks, Tumor, rep 3 Female ERβKOVil, AOM/DS…
- GSM8370282 Female ERβKOVil, AOM/DSS, 15 weeks, Tumor, rep 4 Female ERβKOVil, AOM/DS…
- GSM8370283 Female WT, AOM/DSS, 15 weeks, Tumor, rep 1 Female WT, AOM/DSS, 15 …
- GSM8370284 Female WT, AOM/DSS, 15 weeks, Tumor, rep 2 Female WT, AOM/DSS, 15 …
- GSM8370285 Female WT, AOM/DSS, 15 weeks, Tumor, rep 3 Female WT, AOM/DSS, 15 …
- GSM8370286 Female WT, AOM/DSS, 15 weeks, Tumor, rep 4 Female WT, AOM/DSS, 15 …
- GSM8370287 Female WT, AOM/DSS, 15 weeks, Tumor, rep 5 Female WT, AOM/DSS, 15 …
- GSM8370288 Male ERβKOVil, Vehicle, Scrape, rep 1 Male ERβKOVil, Vehicle,…
- GSM8370289 Male ERβKOVil, Vehicle, Scrape, rep 2 Male ERβKOVil, Vehicle,…
- GSM8370290 Male ERβKOVil, Vehicle, Scrape, rep 3 Male ERβKOVil, Vehicle,…
- GSM8370291 Male ERβKOVil, Vehicle, Scrape, rep 4 Male ERβKOVil, Vehicle,…
- GSM8370292 Male ERβKOVil, Vehicle, Scrape, rep 5 Male ERβKOVil, Vehicle,…
- GSM8370293 Male ERβKOVil, AOM/DSS, 15 weeks, Scrape, rep 1 Male ERβKOVil, AOM/DSS,…
- GSM8370294 Male ERβKOVil, AOM/DSS, 15 weeks, Scrape, rep 2 Male ERβKOVil, AOM/DSS,…
- GSM8370295 Male ERβKOVil, AOM/DSS, 15 weeks, Scrape, rep 3 Male ERβKOVil, AOM/DSS,…
- GSM8370296 Male ERβKOVil, AOM/DSS, 15 weeks, Scrape, rep 4 Male ERβKOVil, AOM/DSS,…
- GSM8370297 Male ERβKOVil, AOM/DSS, 15 weeks, Scrape, rep 5 Male ERβKOVil, AOM/DSS,…
- GSM8370298 Male ERβKOVil, AOM/DSS, 15 weeks, Tumor, rep 1 Male ERβKOVil, AOM/DSS,…
- GSM8370299 Male ERβKOVil, AOM/DSS, 15 weeks, Tumor, rep 2 Male ERβKOVil, AOM/DSS,…
- GSM8370300 Male ERβKOVil, AOM/DSS, 15 weeks, Tumor, rep 3 Male ERβKOVil, AOM/DSS,…
- GSM8370301 Male ERβKOVil, AOM/DSS, 15 weeks, Tumor, rep 4 Male ERβKOVil, AOM/DSS,…
- GSM8370302 Male WT, AOM/DSS, 15 weeks, Tumor, rep 1 Male WT, AOM/DSS, 15 we…
- GSM8370303 Male WT, AOM/DSS, 15 weeks, Tumor, rep 2 Male WT, AOM/DSS, 15 we…
- GSM8370304 Male WT, AOM/DSS, 15 weeks, Tumor, rep 3 Male WT, AOM/DSS, 15 we…
- GSM8370305 Male WT, AOM/DSS, 15 weeks, Tumor, rep 4 Male WT, AOM/DSS, 15 we…
- GSM8370306 Male WT, AOM/DSS, 15 weeks, Tumor, rep 5 Male WT, AOM/DSS, 15 we…
- GSE301459 Elucidating the impact of KRAS Gly12 mutants on homeostasis and tumorigenesis in the colonic epithelium 24 samples shares impact, colon
- GSE278384 Colonic Epithelial-derived FGF1 Protects against Inflammatory Bowel Disease via Driving Intestinal Stem Cells Differentiation toward Goblet Cells 12 samples shares intestinal, colon
- GSE317281 Integrated bulk and single-cell transcriptome analysis reveals the impact of cyclophosphamide on tumor microenvironment in triple-negative breast cancer models 14 samples shares impact
- GSE280084 A Multipotent PROX1+ Tumor Cell Population Emerges During Intestinal Tumorigenesis and Mediates Radioresistance in Colorectal Cancer 13 samples shares intestinal
- GSE300283 The single-cell transcriptome defines an effector Vd1 gd T cell-dependent anti-tumor immunity in human gastrointestinal stromal tumor (GIST) 6 samples shares intestinal
- GSE311912 Probiotics Complex Synergizes with FOLFOX to Enhance Antitumor Response and Ameliorate Chemotherapy-induced Intestinal Toxicity via Upregulation of NAD+ Metabolism 27 samples shares intestinal
- GSE269507 The interleukin 22–oncostatin M axis promotes intestinal inflammation and tumorigenesis [scRNA-seq] 12 samples shares intestinal
- GSE304112 Establishment of sex-specific liver transcriptomes and H3K9me3 profiles during sexual maturity: the impact of maternal obesity [RNA-seq] 32 samples shares impact
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.